Oncology
Oncology
The interventional oncology (IO) device market encompasses many different types of methodical approaches to the treatment of cancer. The oncology device market is broken up into radiation therapy market (RT), which includes internal (RTi) and external (RTx) radiation therapy; ablation, which includes cryoablation therapy, microwave ablation therapy (MAT) and radiofrequency ablation (RFA); and particle embolization, which includes drug-eluting beads, radioembolization, microspheres and polyvinyl alcohol (PVA) particles. View our variety of oncology device market reports below.
“It is clear that you take great care in researching & producing your reports. It shows!”
– Group Manager, Market Research
Intuitive Surgical
Intuitive Surgical
“iData offers a wide variety of reports and their service is very responsive.”
– Strategy & Marketing Department
Acumed
Acumed
“Great insights and high quality data.”
– Head of Sales and Marketing
Distalmotion SA
Distalmotion SA
“Very thorough and easy to access, the iData market research report is a useful reference tool for marketing planning.”
– Senior Product Manager
NuVasive
NuVasive
“Great insights! Reports were very informative for the business.”
– Marketing Manager
Medartis, Inc.
Medartis, Inc.
“The team was very responsive and provided great follow up.”
– Product Marketing Manager
Planmeca USA
Planmeca USA
“Detailed data by product category is useful and easy to understand.”
– Business Development Department
Terumo Corporation
Terumo Corporation
iData Research has an ever-expanding medical market intelligence library consisting of focused, in-depth, accurate, and exclusive research you will not find anywhere else. Our highly qualified team of industry analysts follow a structured and independent research methodology designed to provide the most valuable return on actionable market data in the world.
Showing all 5 results
-
Oncology Market Analysis, Size, Trends | Europe | 2017-2023 | MedSuite (Includes 5 Reports)
Oncology Market Analysis, Size, Trends | Europe | 2017-2023 | MedSuite (Includes 5 Reports)
The European and Middle Eastern (EME) market for the oncology market includes 4 segments: (1) the standard drug needles segment, (2) the open vial access devices segment, (3) the closed system segment and (4) the closed system transfer devices (CSTD) segment. The closed system segment includes 2... more... -
Oncology Market Analysis, Size, Trends | United States | 2016-2022 | MedSuite
Oncology Market Analysis, Size, Trends | United States | 2016-2022 | MedSuite
The transcatheter embolization particle segment is expected to lead the other segments in growth, driven by the strong adoption of radioactive particles, which command significantly higher ASPs. Similarly, the tumor ablation device segment is expected to exhibit market growth due to an ongoing... more... -
Transcatheter Embolization Particles Market Analysis | United States | 2016-2022 | MedCore
Transcatheter Embolization Particles Market Analysis | United States | 2016-2022 | MedCore
Transcatheter embolization is the practice of introducing material to within the vasculature to induce blood flow occlusions. Transcatheter embolization is effective for treating vessel malformations such as aneurysms, fistulae and bleeding. If left untreated, some of these arteriovenous... more... -
Interventional Oncology Devices Procedure Volume Analysis | United States | 2016-2022 | MedPro
Interventional Oncology Devices Procedure Volume Analysis | United States | 2016-2022 | MedPro
The transcatheter embolization particle segment is expected to lead the other segments in growth, driven by the strong adoption of radioactive particles, which command significantly higher ASPs. Similarly, the tumor ablation device segment is expected to exhibit market growth due to an ongoing... more... -
Internal and External Radiation Therapy Devices Market Analysis | United States | 2016-2022 | MedCore
Internal and External Radiation Therapy Devices Market Analysis | United States | 2016-2022 | MedCore
Radiation therapy (RT) is a type of treatment most commonly used against cancer or to control and kill malignant cells. Typically, X-rays, gamma rays or charged particles (CPs) are the medium used. For oncological applications, RT works by attacking a cancerous cells DNA. DNA (deoxyribonucleic... more...
